ConvaTec Group PLC's latest marketcap:
As of 08/03/2025, ConvaTec Group PLC's market capitalization has reached $6.27 B. According to our data, ConvaTec Group PLC is the 2800th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.27 B |
| Revenue (ttm) | 2.28 B |
| Net Income (ttm) | 209.91 M |
| Shares Out | 2.04 B |
| EPS (ttm) | 0.1 |
| Forward PE | 16.52 |
| Ex-Dividend Date | 08/21/2025 |
| Earnings Date | 07/29/2025 |
ConvaTec Group PLC's yearly market capitalization.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/03/2025 | £4.72 B | $6.27 B | 4.36% | 2800 |
| 12/31/2024 | £4.53 B | $5.66 B | -9.11% | 2700 |
| 12/29/2023 | £4.98 B | $6.34 B | 4.77% | 2377 |
| 12/30/2022 | £4.75 B | $5.75 B | 22.28% | 2388 |
| 12/31/2021 | £3.89 B | $5.25 B | -2.42% | 3113 |
| 12/31/2020 | £3.98 B | $5.44 B | 1.32% | 2646 |
| 12/31/2019 | £3.93 B | $5.21 B | 44.21% | 2308 |
| 12/31/2018 | £2.73 B | $3.48 B | -31.12% | 2704 |
| 12/29/2017 | £3.96 B | $5.34 B | -13.3% | 2219 |
| 12/30/2016 | £4.56 B | $5.64 B | 1731 |
Company Profile
About ConvaTec Group PLC
ConvaTec Group PLC is a global medical technology company specializing in the development, manufacturing, and sale of advanced healthcare products and solutions. Headquartered in London, UK, the company has been serving patients and healthcare providers since 1978.
Core Offerings
- Advanced Wound Care: Products designed for acute and chronic wound management, including those caused by diabetes, burns, or traumatic injuries.
- Ostomy Care: Comprehensive solutions, including devices and accessories, for individuals with stomas resulting from colorectal cancer, bladder cancer, or inflammatory bowel disease.
- Continence Care: Specialized products and services for urinary continence issues related to spinal cord injuries, neurological diseases, or prostate enlargement.
- Infusion Care: Disposable infusion sets for diabetes insulin pumps and continuous infusion treatments for conditions like Parkinson’s disease.
Market Presence
ConvaTec operates across Europe, North America, and other international markets. Its products are distributed through pharmacies, hospitals, and healthcare service providers, reaching a diverse customer base that includes patients, healthcare professionals, and manufacturers.
Founded: 1978 | Headquarters: London, United Kingdom
Frequently Asked Questions
-
What is ConvaTec Group PLC's (LON-CTEC) current market cap?As of 08/03/2025, ConvaTec Group PLC (including the parent company, if applicable) has an estimated market capitalization of $6.27 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ConvaTec Group PLC (LON-CTEC) rank globally by market cap?ConvaTec Group PLC global market capitalization ranking is approximately 2800 as of 08/03/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.